PillFurosemide
Brands: Lasix · Furosemide
30 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 39 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it30 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 58 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 46 | SUPPLYING |
| A-S Medication Solutions | unknown | 36 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 22 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 18 | SUPPLYING |
| Proficient Rx LP | unknown | 14 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | unknown | 13 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 12 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 12 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 11 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 11 | SUPPLYING |
| Ipca Laboratories Limited | unknown | 10 | SUPPLYING |
| Marlex Pharmaceuticals Inc | unknown | 9 | SUPPLYING |
| Granulation Technology, Inc. | unknown | 9 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 9 | SUPPLYING |
+ 15 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 31, 2026SHORTAGEDrug shortage: Furosemide Oral Solution (Hikma Pharmaceuticals USA, Inc.)
Furosemide Oral Solution — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.
- Mar 20, 2026RECALLRecall (Class II): Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004…
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. — Recalling firm: Leading Pharma, LLC — US Nationwide.
- Jan 10, 2026RECALLRecall (Class II): Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, N…
Presence of Foreign Substance — Recalling firm: Graviti Pharmaceuticals Private Limited — U.S. Nationwide
- Dec 22, 2016RECALLRecall (Class II): Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-…
Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint. — Recalling firm: Roxane Laboratories, Inc. — Nationwide in the USA
- Sep 25, 2015RECALLRecall (Class III): FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratorie…
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP. — Recalling firm: Boehringer Ingelheim Roxane Inc — Nationwide and Puerto Rico
- Sep 25, 2015RECALLRecall (Class III): FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratorie…
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP. — Recalling firm: Boehringer Ingelheim Roxane Inc — Nationwide and Puerto Rico